ARCHIVES

NCAB Gives President Evidence Supporting Limits On Tar, Nicotine

This article is from The Cancer Letter archive.

Vol. 01 No. 43 | November 29, 1974

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

Minority Professional Training Concept Gets Approval Of NCAB

March 1, 1991

FDA Ceases Exclusion Of Women From Early Drug Studies

May 7, 1993

OMB Backs Down, May Release New Construction Funds For UCLA, Salk, NYU

April 25, 1975

Clinical Trials: Institutions Invited By NSABP To Join Raloxifene Trial

July 10, 1998

International Working Group Suggests Earlier Endpoints For HPV Vaccine Trials

August 29, 2014